Advertisement

Science News

Confirmed: For Black Americans, Biktarvy Effectively Controls HIV

illustration black and white clock hand with vaccine syringe

A Shot in the Dark: The Quest for an HIV Vaccine

HIV Treatment: 40 Years of Innovation

Confirmed: For Black Americans, Biktarvy Effectively Controls HIV

illustration black and white clock hand with vaccine syringe

A Shot in the Dark: The Quest for an HIV Vaccine

HIV Treatment: 40 Years of Innovation

SARS-CoV-2 and HIV

Are People Living With HIV at Greater Risk for COVID-19?

Two new analyses come to different conclusions about the risk for severe illness and death.

Don’t Rush Black Women With Same-Day HIV PrEP Starts

Ample information, respectful interactions with clinicians and follow-up could be keys to supporting Black women in the South to use PrEP.

Twice-Yearly Lenacapavir Works Well for People with Highly Resistant HIV

The novel HIV capsid inhibitor also shows promise for previously untreated people.

What Will Bring People Living With HIV Back Into Care?

Hint: It’s not HIV-care-as-usual approaches.

Gender-Affirming Care Plus HIV PrEP Coming to Houston (and Elsewhere)

Study will test whether providing both together will improve HIV protection for trans women.

MUST read

Gene Editing Delays Viral Rebound During HIV Treatment Interruption

a US dollar symbol in a life preserver

Some People With HIV Don’t Adhere to Treatment to Save Money

There’s Never Been a Better Time to Get Pregnant If One of You Has HIV

POZ March 2019 cover U=U Undetectable = Untransmitable

Communicating Undetectable Equals Untransmittable

The Science Is Clear: With HIV, Undetectable Equals Untransmittable

4 in 5 HIV Transmissions Likely Come From Those Not in Care for the Virus

Anatomical model of rectum and anus

Cisgender Women’s Rectal Tissue May Be More Vulnerable to HIV Than Men’s

What this means for women’s HIV acquisition rates is unclear.

Indigenous People With HIV Are Twice as Likely to Be Hospitalized as White People

Disparities extend from HIV acquisition all the way through to hospitalization and AIDS-defining illnesses.

Untangling Why Young People Don’t Take PrEP

Awareness of the HIV prevention pills don’t match their use.

Female reproductive system

Women With HIV Are at Greater Risk for Cervical Cancer

Study suggests HIV-positive women could start cervical cancer screening at age 21.

8% of Teens With HIV Had AIDS-Defining Illnesses After Transitioning to Adult Care

Immigrants and girls had worse HIV outcomes in this study.

Hot topics

#Cure

#Long-Term Survivors

Ounce of Prevention sign against a blue sky

#Prevention

PrEP written on a chalkboard

#PrEP

People With HIV Have High Levels of Inflammation and Coronary Plaque

White men and smokers are more likely to have arterial plaque despite low cardiovascular risk scores.

Should the HIV Care Continuum Include Leaving Care?

The current design of the HIV care continuum is a straight line from diagnosis to an undetectable viral load.

People With HIV Are Highly Satisfied With Cabenuva

Injections given every month or every other month were preferred over daily pills.

Javitz Center COVID-19 vaccine site in New York City

Single-Shot COVID-19 Vaccine Produces Immune Response Against Variants

The immune response to the single-shot Johnson & Johnson vaccine remained robust against variants of SARS-CoV-2.

Advertisement

Features

Newsfeed

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ